Abivax ADR
Abivax ADR (ABVX) Expected Move
ABVX expected move through Sep 18, 2026 is 5.3%, with 0 days to expiration. The implied range is $101.60 to $112.38, based on the previous trading day's options prices.
Read more
Tracking the ABVX expected move helps you see how far Abivax ADR's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Abivax ADR's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the ABVX expected move for this week's options, in real time.
The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For ABVX, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The ABVX expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Abivax ADR is unlikely to go.
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer.
In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.
Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the ABVX expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Abivax ADR expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about ABVX.
ABVX Price
Drag chart to pan. Drag axes to zoom.
| Expiration | DTE | Expected move (USD) | Expected move (%) | Upper price | Lower price |
|---|---|---|---|---|---|
| Sep 18, 2026 | 0 | $5.39 | 5.3% | $112.38 | $101.60 |
| Sep 25, 2026 | 7 | $11.93 | 11.7% | $118.91 | $95.07 |
| Oct 2, 2026 | 14 | $15.18 | 14.8% | $122.16 | $91.82 |
| Oct 9, 2026 | 21 | $17.40 | 17.0% | $124.39 | $89.59 |
As of September 16, 2026
Know What the Market Expects From ABVX
Track the ABVX expected move across every expiration, filter by IV rank and liquidity, and trade around the range the market is already pricing in.
Start your 14-day free trial→